Zobrazeno 1 - 10
of 21
pro vyhledávání: '"David J. Witt"'
Autor:
Jennifer O Lam, David J. Witt, Varun Saxena, Michael J. Silverberg, Leo B. Hurley, Scott Chamberland, Jamila H. Champsi, Jennifer B. Lai, Julia L. Marcus, Charles P. Quesenberry, Joanna Ready, Daniel G. Korn, Suk I. Seo
Publikováno v:
Open Forum Infectious Diseases
Among 25 291 and 4 921 830 people with and without hepatitis C, life expectancy at age 20 increased 1.8 years and 0.3 years from the interferon to interferon-free era, respectively. Increases were highest for racial and/or ethnic minority groups with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77053fd336aa9b37d92aaf7b151fc713
https://doi.org/10.1093/ofid/ofaa044
https://doi.org/10.1093/ofid/ofaa044
Autor:
Laura C. Gittleman, Michael J. Silverberg, Joanna Ready, Mary Patricia Pauly, Jennifer O Lam, Scott Chamberland, Daniel G. Korn, Julia L. Marcus, Jamila H. Champsi, Jennifer B. Lai, Suk I. Seo, Leo B. Hurley, Charles P. Quesenberry, Varun Saxena, David J. Witt
Publikováno v:
Clinical Gastroenterology and Hepatology. 16:927-935
BACKGROUND & AIMS: Treatment with the combination of ledipasvir and sofosbuvir for 12 weeks has been approved by the Food and Drug Administration for patients with genotype 1 hepatitis C virus (HCV) infection; some patients can be treated with an 8-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ca2f339f041c907cbeb67cacd24bf70
https://doi.org/10.1016/j.cgh.2018.03.003
https://doi.org/10.1016/j.cgh.2018.03.003
Autor:
Daniel G. Korn, Michael J. Silverberg, Joanna Ready, Julia L. Marcus, Varun Saxena, Jennifer O Lam, Leo B. Hurley, Scott Chamberland, Charles P. Quesenberry, Mary Pat Pauly, Jamila H. Champsi, Jennifer B. Lai, Suk I. Seo, Laura C. Gittleman, David J. Witt
Publikováno v:
Public Health Reports. 133:452-460
Objectives: The cost of direct-acting antiviral agents (DAAs) for hepatitis C virus (HCV) infection may contribute to treatment disparities. However, few data exist on factors associated with DAA initiation. Methods: We conducted a retrospective coho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd16897b0e8ae9f3c2d638d9c2d16d70
https://doi.org/10.1177/0033354918772059
https://doi.org/10.1177/0033354918772059
Publikováno v:
AJN, American Journal of Nursing. 117:58-63
Resistance to antibiotics has increased dramatically in the United States, with serious associated medical, social, and economic consequences. The most promising approach to this national crisis is a new understanding of the need for the careful and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a5115117689996611dc841471be143
https://doi.org/10.1097/01.naj.0000521974.76835.e0
https://doi.org/10.1097/01.naj.0000521974.76835.e0
Autor:
Mary Patricia Pauly, Jennifer B. Lai, Suk I. Seo, Maxwell A. Witt, Michael Allerton, David J. Witt, Joanna Ready
Publikováno v:
Drugs. 77:313-318
Second-generation direct-acting antiviral agents are integral to treatment of hepatitis C (HCV) infection. Eight-week courses of ledipasvir/sofosbuvir (LDV/SOF) have been supported in some studies, but data are limited on efficacy in real-world use.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54e9211f14e89b42152dd3ea78e021ed
https://doi.org/10.1007/s40265-016-0684-y
https://doi.org/10.1007/s40265-016-0684-y
Autor:
Daniel G. Korn, Michael J. Silverberg, Scott Chamberland, Varun Saxena, Suk I. Seo, David J. Witt, Jamila H. Champsi, Julia L. Marcus, Laura C. Gittleman, Jennifer B. Lai, Leo B. Hurley, Jennifer O Lam, Joanna Ready, Charles P. Quesenberry
Publikováno v:
International journal of STDAIDS. 30(7)
U.S. guidelines recommend that patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) be prioritized for HCV treatment with direct-acting antiviral agents (DAAs), but the high cost of DAAs may contribute to disparitie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3350b1cc6b3e401c27626492470e8319
https://pubmed.ncbi.nlm.nih.gov/31046611
https://pubmed.ncbi.nlm.nih.gov/31046611
Publikováno v:
American journal of infection control. 47(4)
The Abstracts Committee of the Association for Professionals in Infection Control and Epidemiology noted high rejection rates for submitted abstracts, often for minor infractions of guidelines. This study examines the reasons for abstract rejection a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5f65c8e74b83ffb913ad7f23b5f2331
https://pubmed.ncbi.nlm.nih.gov/30527281
https://pubmed.ncbi.nlm.nih.gov/30527281
Autor:
David J. Witt, Cristine C Lacerna, Stephen Parodi, Lawrence Block, Melanie Parker, Yulia Kevorkova, Robin Betts, Jessica Galin, Donna Patey, Sejal Naik
Publikováno v:
Open Forum Infectious Diseases
Background Non-Ventilator Hospital-acquired Pneumonia (HAP) is a prevalent healthcare-associated infection with mortality of 21%. HAP prevention literature is scant. We developed a definition enabling accurate surveillance to support this effort and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd906d40192ff1ea6ddf343cfb6f7a6d
https://doi.org/10.1093/ofid/ofz360.1044
https://doi.org/10.1093/ofid/ofz360.1044
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background. Despite widespread childhood vaccination against Bordetella pertussis, disease remains prevalent. It has been suggested that acellular vaccine may be less effective than previously believed. During a large outbreak, we examined the incide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a02a9f147f22ffac0ef1c0baa6eea3d4
https://doi.org/10.1093/cid/cis287
https://doi.org/10.1093/cid/cis287